NO900577L - CYCLOSPOR-CONTAINING PREPARATIONS AND PROCEDURES FOR THEIR PREPARATION. - Google Patents

CYCLOSPOR-CONTAINING PREPARATIONS AND PROCEDURES FOR THEIR PREPARATION.

Info

Publication number
NO900577L
NO900577L NO90900577A NO900577A NO900577L NO 900577 L NO900577 L NO 900577L NO 90900577 A NO90900577 A NO 90900577A NO 900577 A NO900577 A NO 900577A NO 900577 L NO900577 L NO 900577L
Authority
NO
Norway
Prior art keywords
cyclospor
procedures
preparation
containing preparations
preparations
Prior art date
Application number
NO90900577A
Other languages
Norwegian (no)
Other versions
NO301576B1 (en
NO900577D0 (en
Inventor
Birgit Hauer
Ulrich Posanski
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898902898A external-priority patent/GB8902898D0/en
Priority claimed from GB898902901A external-priority patent/GB8902901D0/en
Priority claimed from GB898903147A external-priority patent/GB8903147D0/en
Priority claimed from GB898903663A external-priority patent/GB8903663D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO900577D0 publication Critical patent/NO900577D0/en
Publication of NO900577L publication Critical patent/NO900577L/en
Publication of NO301576B1 publication Critical patent/NO301576B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
NO900577A 1989-02-09 1990-02-07 Process for the preparation of a pharmaceutical composition having immunosuppressive activity NO301576B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB898902898A GB8902898D0 (en) 1989-02-09 1989-02-09 Improvements in or relating to organic compounds
GB898902901A GB8902901D0 (en) 1989-02-09 1989-02-09 Improvements in or relating to organic compounds
GB898903147A GB8903147D0 (en) 1989-02-13 1989-02-13 Improvements in or relating to organic compounds
GB898903663A GB8903663D0 (en) 1989-02-17 1989-02-17 Improvements in or relating to organic compounds

Publications (3)

Publication Number Publication Date
NO900577D0 NO900577D0 (en) 1990-02-07
NO900577L true NO900577L (en) 1990-08-10
NO301576B1 NO301576B1 (en) 1997-11-17

Family

ID=27450262

Family Applications (1)

Application Number Title Priority Date Filing Date
NO900577A NO301576B1 (en) 1989-02-09 1990-02-07 Process for the preparation of a pharmaceutical composition having immunosuppressive activity

Country Status (25)

Country Link
JP (3) JP3484190B2 (en)
KR (1) KR0170769B1 (en)
AT (1) AT404552B (en)
AU (1) AU630413B2 (en)
BE (1) BE1003009A5 (en)
CA (1) CA2009533C (en)
CH (1) CH679277A5 (en)
CY (1) CY1903A (en)
DE (1) DE4003844B4 (en)
DK (1) DK176209B1 (en)
ES (1) ES2021942A6 (en)
FI (1) FI97524C (en)
FR (1) FR2642650B1 (en)
GB (1) GB2230440B (en)
HK (1) HK37296A (en)
HU (1) HU213394B (en)
IT (1) IT1240758B (en)
LU (1) LU87675A1 (en)
MY (1) MY107377A (en)
NL (1) NL195028C (en)
NO (1) NO301576B1 (en)
NZ (1) NZ232401A (en)
PH (1) PH30917A (en)
PT (1) PT93079B (en)
SE (1) SE511398C2 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (en) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 A multiphase cyclosporin composition
HU208491B (en) * 1990-11-27 1993-11-29 Gyogyszerkutato Intezet Process for producing oral pharmaceutical composition containing cyclosporin
MX9201782A (en) † 1991-04-19 1992-10-01 Sandoz Ag PARTICLES OF BIOLOGICALLY ACTIVE SUBSTANCES, SUBSTANTIALLY INSOLUBLE IN WATER, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
EP0642332B1 (en) 1992-05-13 1997-01-15 Sandoz Ltd. Ophthalmic compositions containing a cyclosporin
US5759566A (en) * 1992-07-28 1998-06-02 Poli Industria Chimica Spa Microemulsion pharmaceutical compositions for the delivery of pharmaceutically active agents
DK0589843T3 (en) 1992-09-25 2002-04-02 Novartis Ag Cyclosporin-containing pharmaceutical preparations
ATE218878T1 (en) * 1993-04-20 2002-06-15 Novartis Erfind Verwalt Gmbh NEW PHARMACEUTICAL PREPARATIONS FOR ORAL ADMINISTRATION CONTAINING CYCLOSPORINE
DE4412201A1 (en) * 1993-04-20 1994-11-10 Rentschler Arzneimittel New pharmaceutical preparations for oral administration containing cyclosporin
DE4340781C3 (en) * 1993-11-30 2000-01-27 Novartis Ag Liquid preparations containing cyclosporin and process for their preparation
KR0146671B1 (en) * 1994-02-25 1998-08-17 김충환 Cyclosporin-containing powder composition
PT789580E (en) 1994-11-03 2002-09-30 Novartis Ag CYCLOSPORINE FORMULATIONS FOR ORAL ADMINISTRATION WITH SIMPLE COMPOSITION AND HIGH BIODISPONIBILITY AND PROCESS FOR ITS PRODUCTION
US5679566A (en) * 1995-01-20 1997-10-21 University Of Massachusetts Medical Center Yeast NMD2 gene
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
DE19544507B4 (en) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin containing preparations
US5798333A (en) * 1996-09-17 1998-08-25 Sherman; Bernard C. Water-soluble concentrates containing cyclosporins
AU762247B2 (en) * 1997-01-30 2003-06-19 Novartis Ag Oil-free pharmaceutical compositions containing cyclosporin A
IL130797A0 (en) 1997-01-30 2001-01-28 Novartis Ag Hard gelatine capsules containing pharmaceutical compositions substantially free of any oil
CZ301382B6 (en) * 1997-03-12 2010-02-10 Abbott Laboratories Chad377/Ap6D-2 Hydrophilic binary systems for administering cyclosporin
NZ328751A (en) * 1997-09-16 1999-01-28 Bernard Charles Sherman Solid medicament containing an anionic surfactant and cyclosporin
US6447806B1 (en) 1999-02-25 2002-09-10 Novartis Ag Pharmaceutical compositions comprised of stabilized peptide particles
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
JP4521554B2 (en) * 2004-03-31 2010-08-11 マイラン製薬株式会社 Cyclosporine preparation
JP5406530B2 (en) * 2005-10-26 2014-02-05 バナー ファーマキャプス， インコーポレイテッド Dual controlled release matrix system based on hydrophilic vehicle
AU2007230716B2 (en) 2006-03-28 2012-05-03 Javelin Pharmaceuticals, Inc. Formulations of low dose diclofenac and beta-cyclodextrin
US7495024B2 (en) 2006-08-07 2009-02-24 Via Pharmaceuticals, Inc. Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque
DE102008059201A1 (en) 2008-11-27 2010-06-02 GÖPFERICH, Achim, Prof. Dr. In situ precipitating drug solutions
KR102146704B1 (en) 2018-04-13 2020-08-21 가천대학교 산학협력단 Cyclosporin a containing microstructures for transdermal and intradermal drug delivery
WO2023063376A1 (en) * 2021-10-13 2023-04-20 中外製薬株式会社 Composition including peptide compound and surfactant

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI65914C (en) * 1978-03-07 1984-08-10 Sandoz Ag FRAMEWORK FOR PHARMACEUTICAL COMPOSITION OF CYCLOSPORINE A
JPS61280435A (en) * 1985-04-04 1986-12-11 Kanji Takada Lymph orienting preparation of cyclosporin
NL8600050A (en) * 1986-01-13 1987-08-03 Sanico Nv PHARMACEUTICAL PREPARATION WITH DELAYED DELIVERY OF THE ACTIVE SUBSTANCE AND METHOD FOR PREPARING IT.
GB8602372D0 (en) * 1986-01-31 1986-03-05 Sandoz Ltd Organic compounds
CA1290249C (en) * 1986-04-09 1991-10-08 Cetus Corporation COMBINATION THERAPY USING INTERLEUKIN-2 AND/OR INTERFERON-.beta. AND TUMOR NECROSIS FACTOR
CA1341374C (en) * 1986-11-13 2002-07-09 Alan N. Houghton Compositions and method for treatment of cancer using monoclonal antibody against gd3 ganglioside together with il-2
ES2059558T3 (en) * 1987-06-17 1994-11-16 Sandoz Ag CYCLOSPORINS AND THEIR USE AS PHARMACEUTICAL PRODUCTS.
JP2536876B2 (en) * 1987-07-31 1996-09-25 寛治 高田 Dissolvable powder formulation of cyclosporine
DE3830494B4 (en) * 1987-09-15 2006-05-18 Novartis Ag Water-soluble monoesters as solubilizers for pharmacologically active substances and pharmaceutical excipients
US5756450A (en) * 1987-09-15 1998-05-26 Novartis Corporation Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
HU205010B (en) * 1987-09-15 1992-03-30 Sandoz Ag Process for producing pharmaceutical compositions comprising compounds soluble up to 1 per cent and having medical activity
JP2792862B2 (en) * 1988-07-30 1998-09-03 寛治 高田 Oral enteric formulation
KR0148748B1 (en) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 A multiphase cyclosporin composition
JPH1038029A (en) * 1996-07-26 1998-02-13 Ebara Corp Dick shape structure with vibration damping function
JPH10280435A (en) * 1997-04-03 1998-10-20 Sekisui Chem Co Ltd Construction method of basement

Also Published As

Publication number Publication date
NL195028C (en) 2003-12-02
JP2001302538A (en) 2001-10-31
HU900701D0 (en) 1990-04-28
FI97524B (en) 1996-09-30
NZ232401A (en) 1992-10-28
ATA27290A (en) 1998-05-15
CA2009533C (en) 2002-11-12
DE4003844A1 (en) 1990-08-16
CH679277A5 (en) 1992-01-31
JP2006001947A (en) 2006-01-05
KR0170769B1 (en) 1999-02-01
IT9047609A0 (en) 1990-02-08
HU213394B (en) 1997-06-30
CA2009533A1 (en) 1990-08-09
FR2642650B1 (en) 1994-12-09
IT1240758B (en) 1993-12-17
IT9047609A1 (en) 1991-08-08
JP3484190B2 (en) 2004-01-06
PT93079A (en) 1990-08-31
JPH02235817A (en) 1990-09-18
FI97524C (en) 1997-01-10
LU87675A1 (en) 1991-10-08
BE1003009A5 (en) 1991-10-22
ES2021942A6 (en) 1991-11-16
NO301576B1 (en) 1997-11-17
AU4925290A (en) 1990-08-16
NL9000299A (en) 1990-09-03
NL195028B (en) 2003-08-01
CY1903A (en) 1996-11-22
NO900577D0 (en) 1990-02-07
SE9000441D0 (en) 1990-02-07
DK32790A (en) 1990-08-10
JP4073641B2 (en) 2008-04-09
DK32790D0 (en) 1990-02-07
FR2642650A1 (en) 1990-08-10
DE4003844B4 (en) 2007-09-20
PH30917A (en) 1997-12-23
GB2230440A (en) 1990-10-24
DK176209B1 (en) 2007-02-05
GB2230440B (en) 1993-05-19
PT93079B (en) 1996-04-30
GB9002504D0 (en) 1990-04-04
SE9000441L (en) 1991-08-08
FI900604A0 (en) 1990-02-07
MY107377A (en) 1995-11-30
SE511398C2 (en) 1999-09-20
AU630413B2 (en) 1992-10-29
KR900012625A (en) 1990-09-01
HK37296A (en) 1996-03-15
AT404552B (en) 1998-12-28

Similar Documents

Publication Publication Date Title
NO900577L (en) CYCLOSPOR-CONTAINING PREPARATIONS AND PROCEDURES FOR THEIR PREPARATION.
NO893678D0 (en) CYCLOSPOR-CONTAINING PREPARATIONS AND PROCEDURES FOR THEIR PREPARATION.
NO881660D0 (en) HEPARINES AND FIVE TIMES FOR THEIR PREPARATION.
NO894266D0 (en) CONTRACTING PREPARATIONS AND PROCEDURES FOR THEIR PREPARATION.
NO904551D0 (en) QUINOLONE COMPOUNDS AND PROCEDURES FOR THEIR PREPARATION.
NO875358L (en) 6-BENZOCSAZINYL AND 6-BENZOTIAZINYL-2,3,4,5-TETRAHYDROPYRIDAZINE-3-ONES AND PROCEDURES FOR THEIR PREPARATION.
NO893196D0 (en) HYBRID-PROTEIN-C COMPOSITIONS AND PROCEDURES FOR THEIR PREPARATION.
NO900312L (en) GALLIUM SUSPENSIONS AND PROCEDURES FOR THEIR PREPARATION.
NO910003L (en) VITAMIN E-DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION.
NO903636D0 (en) MACROCYCLIC RELATIONS AND PROCEDURE FOR THEIR PREPARATION.
NO882766L (en) CATALYSTS AND PROCEDURES FOR THEIR PREPARATION.
NO894624L (en) COPOLYMERS AND PROCEDURES FOR THEIR PREPARATION.
NO903096L (en) THERMOTROP SEMIALIFATIC COPOLYESTERAMIDS AND THEIR PREPARATION.
DK304090A (en) GLYCEROLD DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND THERAPEUTIC PREPARATIONS CONTAINING THESE
NO904552D0 (en) QUINOLONE COMPOUNDS AND PROCEDURES FOR THEIR PREPARATION.
DK393489A (en) BENZODIAZEP RELATIONS AND PROCEDURES FOR THEIR PREPARATION
NO883114L (en) 1H-PYRAZOL-1-ALKANAMIDES AND PROCEDURES FOR THEIR PREPARATION.
NO911047L (en) LABDANS AND PROCEDURES FOR THEIR PREPARATION.
NO871634D0 (en) PLANT PREPARATIONS AND PROCEDURES FOR THEIR PREPARATION.
NO900252L (en) CEFASPORIN DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF.
NO903484D0 (en) SUBSTITUTED PYRAZINE DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION.
NO893565L (en) ETHANSULPHONAMIDE DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION.
NO894697D0 (en) PENEME DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION.
NO884167D0 (en) MATTERED POLYMER PREPARATIONS AND PROCEDURES FOR THEIR PREPARATION.
DK180588D0 (en) ANTI-TUMOR-EFFECTIVE PREPARATIONS AND PROCEDURES FOR THEIR PREPARATION

Legal Events

Date Code Title Description
MK1K Patent expired